Testicular cancer research
Around 2,100 men are diagnosed with testicular cancer in the UK every year, and the number of cases has increased significantly over recent decades.
But the good news is that survival rates have increased dramatically. More than nine out of ten men with the disease are now cured. This is partly due to a drug called cisplatin, which Cancer Research UK helped to develop. But testicular cancer still causes around 70 deaths each year in the UK.
You can find out more about testicular cancer on our patient website, CancerHelp UK.
Below are some of the highlights of our testicular cancer research portfolio.
Chemotherapy
Dr Robert Huddart
Section of Radiotherapy
The Institute of Cancer Research, Sutton
Comparing chemotherapy combinations for germ cell cancers
Dr Robert Huddart at The Institute of Cancer Research in Sutton is leading a clinical trial looking at germ cell cancers in men. Germ cells in men go on to develop into sperm. Most germ cell cancers in men happen in the testicles but they can occur elsewhere in the body.
Clinical trials
Dr Robert Huddart
Section of Radiotherapy
The Institute of Cancer Research, Sutton
Comparing chemotherapy combinations for germ cell cancers
Dr Robert Huddart at The Institute of Cancer Research in Sutton is leading a clinical trial looking at germ cell cancers in men. Germ cells in men go on to develop into sperm. Most germ cell cancers in men happen in the testicles but they can occur elsewhere in the body.
